Trial intelligence / Profile preview

SodiUm SeleniTe Administration IN Cardiac Surgery

2013-003088-76Phase 3Completed

Sponsor
Clinical Evaluation Research Unit
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cardiac morbidity comparing Selenium (selenase) arm with Placebo arm (2 arms). Primary endpoint: Persistent organ dysfunction + death (PODS + Death). Started Jan 2014; status: completed.

02

Drugs

sodium selenite
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on 2013-003088-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003088-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call